Skip to content

Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl-sedation for Flexible Bronchoscopy: A Randomized, Single Blind, Controlled Study of Satisfaction and Safety.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02226328
Enrollment
128
Registered
2014-08-27
Start date
2014-11-30
Completion date
2016-04-30
Last updated
2015-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Flexible Bronchoscopy, Safety, Satisfaction, Sedation

Brief summary

Flexible bronchoscopy almost always requires sedation to be successful. In order to increase the availability of propofol for sedation, non-anaesthesiologist administered propofol sedation has been suggested as an alternative to traditional midazolam/opioid sedation or the general anaesthesia provided by anaesthesiologists. Hypothesis: Patients undergoing flexible bronchoscopy prefers non-anaesthesiologist administered sedation with propofol as opposed to non-anaesthesiologist administered sedation with midazolam and fentanyl. Propofol sedation is as safe as midazolam and fentanyl sedation.

Interventions

DRUGMidazolam and Fentanyl sedation

Sponsors

Copenhagen University Hospital at Herlev
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Elective flexible bronchoscopy. 2. Willing to be randomised 3. Provide written informed consent

Exclusion criteria

1. Allergy to contents administered 2. pregnant or nursing 3. \<18 years of age 4. Not able to complete questionnaire 5. Acute condition 6. severe COPD 7. \> ASA II 8. Sleep apnea 9. Risk of aspiration 10. Previously difficulty with anesthesia 11. Difficult airway

Design outcomes

Primary

MeasureTime frameDescription
Satisfaction with sedationAt discharge, on average 30 minutes after procedure termination.The average duration of bronchoscopy is estimated to 20 minutes. A validated satisfaction questionnaire will be filled by the patient at discharge from the recovery room, on average 30 minutes after completed procedure. Readiness for discharge will be assessed using an Aldrete score.

Secondary

MeasureTime frameDescription
Number of adverse events as a surrogate marker of safety.During procedure. On average 20 minutes.Adverse events as a dichotomous value of no event or event. Events are: The use of rescue medicine, and cardiopulmonary support per-operatively, blood pressure deviation from baseline over 30% of Mean Arterial Pressure, oxygen saturation \< 90%, and arrhythmias will be recorded for the duration of the procedure.

Other

MeasureTime frameDescription
Patient comfortPer-operatively, on average 20 minutesPatient discomfort/comfort will be registered on a validated scale during the procedure and recorded by the endoscopy nurse. If the procedure was unsuccessful due to discomfort, this will also be recorded.

Countries

Denmark

Contacts

Primary ContactJeppe Thue Jensen, MD
jeppe.thue.jensen.01@regionh.dk004526136032
Backup ContactPaul F Clementsen, Professor
paul.clementsen@regionh.dk0045 39 77 39 77

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026